ROKIT America, Inc. (RKAM)
ROKIT America will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
| Market Cap | n/a |
| Revenue (ttm) | 7.43M |
| Net Income (ttm) | 1.59M |
| Shares Out | n/a |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About RKAM
ROKIT America is committed to extending human healthspan and enhancing quality of life in an aging society through its proprietary Reverse Aging Product which is intended to support cellular health and aging-related biological processes at the molecular level, and its artificial intelligence hyper-personalized Organ Regeneration Platform, a proprietary technology developed by our parent company, ROKIT Healthcare, which is intended to provide regenerative medicine solutions in the Americas. Since its founding in 2019, the Company has focused on ... [Read more]
Industry Packaged Foods
Sector Consumer Staples
Founded 2019
Country United States
Stock Exchange NASDAQ
Ticker Symbol RKAM
Website https://rokitamerica.co.kr/
News
ROKIT America IPO Registration Document (S-1)
ROKIT America has filed to go public with an IPO on the NASDAQ
13 days ago - SEC